A

Avilar Therapeutics

20 employees

Avilar Therapeutics is a biopharmaceutical company focusing on extracellular protein degradation.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Pharmaceutical

Date founded

2020

Funding rounds raised

Total raised

$60M

from 5 investors over 5 rounds

A

Avilar Therapeutics raised $15M on February 16, 2023

Investors: Sanofi Ventures, Astellas Venture Capital L.L.C., RA Capital Management, L.P. and Medical Excellence Capital, LLC

A

Avilar Therapeutics raised $60M on November 18, 2021

Investors: RA Capital Management, L.P.

FAQ